Press Release
Cell and Gene Therapy Catapult annual review shows investment in the UK advanced therapy industry returned to growth in 2024Plurify and the Cell and Gene Therapy Catapult to develop technology that improves purity of cell therapiesCGT Catapult establishing digital and automation testbeds to enable the scale-up of advanced therapy manufacturingUK and Swiss consortium to apply innovative technologies to lower cost of manufacturing cell and gene therapiesTouchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapiesJim Faulkner, Nicole Mather and Carolyn Porter join the Cell and Gene Therapy Catapult as Non-Executive Directors£17.9m for Advanced Therapy Treatment Centre network to bolster clinical trial infrastructure in the UK: NIHR, Innovate UK and CGT Catapult align strategically to further improve patient access and the UK’s leadershipBraintree Manufacturing Innovation Centre receives MHRA licence to manufacture advanced therapiesEducation Secretary joins Cell and Gene Therapy Catapult to celebrate apprenticesUK maintains its position as an attractive destination for advanced therapy clinical trialsCell and Gene Therapy Catapult announces successful renewal of its five-year funding from Innovate UK to further support the advanced therapies sectorLeading industry surveys demonstrate continued growth in the UK’s cell and gene therapy sector